Loading...
Chronic Experimental Diabetes Accelerates Urinary Elimination of Deprenyl and its Metabolites
Many diabetic patients take several medications to treat diabetes-associated complications and other ailments. The mode of elimination of these drugs and their metabolites are poorly understood. The elimination of deprenyl, a MAO-B inhibitor, used for the treatment of the early stage of Parkinson’s...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Bentham Science Publishers Ltd.
2008
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2709476/ https://ncbi.nlm.nih.gov/pubmed/19662137 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1874104500802010001 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|